News

Read February eNews: Where to find Your Life Science Connections, featuring:


✅ Welcome from Tony Jones, CEO, One Nucleus


✅ Moving Forward Together


✅ Is it Rocket Science? 


✅ Use One Nucleus' High Profile Initiatives to Reach Your Audience


✅ Narrowing the Odds on Success


✅ Nominate Your Life Sciences Inspiration of the Year Award 2024


✅ Upcoming Events for Your Diary


New NGS Laboratory opens its doors for genomics researchers.


Azenta Life Sciences will officially open its new GENEWIZ Multiomics and Synthesis Solutions laboratory in Oxford, UK in March 2024. As a global provider of R&D genomics services, Azenta leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before.

1 February 2024 - Cambridge, UK - Maxion Therapeutics (“Maxion”), the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announced today that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to its next phase of development.

29 February 2024 | The Garden Room, St John’s Innovation Centre, Cambridge


It’s never too early to start planning your business exit. Business exit strategy experts Yellowyoyo have teamed up with Innovate UK EDGE to deliver an essential event for founders that will set you on the road to maximising value, whether you plan to exit in five years or fifty years. Do you plan to sell your business, pass it to your chosen successor, merge with another company or stay on in a new role? Whatever your preferred exit, the time to start preparing is now.

CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC market

• Wes Streeting, Shadow Health Minister, and Peter Kyle, Shadow Science Minister launch Life Sciences Strategy at Stevenage Bioscience Catalyst (SBC).


• Shadow Ministers take part in roundtable discussion with key industry figures including AstraZeneca, GSK, BioIndustry Association (BIA) and Stevenage Bioscience Catalyst and its high growth companies to hear at first hand the opportunities and challenges facing the sector and the vibrant strength of the UK’s life science ecosystem.

Source Genomics Expands Sequencing Portfolio with First UK Commercial Service on the Element Biosciences AVITI™ System


Cambridge, UK, 31 January 2024: Source Genomics, a part of the Source BioScience Group, today announced their genomic laboratory expansion by adding an Element Biosciences AVITI™ System to its fleet of sequencers.

Pioneer Group, a company combining laboratory development and operation with venture building, has teamed up with CPI, the independent deep tech innovation organisation, to launch a Golden Ticket programme for innovations in planetary health.

This week the University of Cambridge announce the appointment of Dr Diarmuid O'Brien, current Chief Executive of Cambridge Enterprise, as their new Pro-Vice-Chancellor of Innovation. 


Click here to read the full story.


London, UK - Award-winning science communications agency First Create The Media is delighted to announce the appointment of Dr Sarah Hazell as its new Chief Executive Officer.


Founded in 2018 by renowned science writer and broadcaster Dr Kat Arney, First Create The Media has quickly become a prominent player in the life sciences sector. The agency brings together a team of experts with decades of experience to provide strategic communications consultancy and high quality written, audio and video content for innovative companies and the ecosystem that supports them.

Pages